| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 29.906 | 60.962 | 65.088 | 74.248 |
| Total Income - EUR | - | - | - | - | - | - | 29.906 | 62.517 | 65.632 | 74.314 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.035 | 30.264 | 36.988 | 36.842 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 28.871 | 32.253 | 28.644 | 37.472 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 28.072 | 30.739 | 28.091 | 35.289 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Cde Endo Diab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 9.750 | 50.114 | 36.163 | 19.170 |
| Current Assets | - | - | - | - | - | - | 18.668 | 17.174 | 25.961 | 37.031 |
| Inventories | - | - | - | - | - | - | 0 | 25 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 284 | 711 | 0 | 10.926 |
| Cash | - | - | - | - | - | - | 18.384 | 16.438 | 25.961 | 26.105 |
| Shareholders Funds | - | - | - | - | - | - | 28.113 | 31.511 | 33.665 | 35.337 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 305 | 35.777 | 28.478 | 21.120 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cde Endo Diab S.r.l.